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Abstract
Hazardous alcohol consumption has been frequently reported among women with HIV infection 
and is associated with a variety of negative health consequences. Treatments to reduce alcohol use 
may bring in health benefits. However, little is known regarding the utilization of alcohol 
treatment services among HIV+ women with hazardous drinking. Using data from the Women’s 
Interagency HIV Study (WIHS), this study assessed utilization of any alcohol treatment in the past 
6 months and performed multivariable logistic regression to determine correlates of receipt of any 
alcohol treatment. Among 474 HIV+ women reporting recent hazardous drinking, less than one in 
five (19%) reported recent utilization of any alcohol treatment. Alcoholics Anonymous (AA) was 
the most commonly reported (12.9%), followed by inpatient detoxification (9.9%) and outpatient 
alcohol treatment program (7.0%). Half (51%) receiving any alcohol treatment reported utilization 
of multiple treatments. Multivariable analyses found alcohol treatment was more often utilized by 
those who had social support (Odds ratio [OR]=1.68, 95% Confidence Interval [CI]=1.00 to 2.83), 
fewer economic resources (income <=$12,000 vs. >$12,000, OR = 3.10, 95% CI=1.53 to 6.27), 
higher levels of drinking (16–35 drinks/week vs. 12–15 drinks/week, OR=3.02, 95% CI=1.47 to 
6.21; 36+ drinks/week vs. 12–15 drinks/week, OR=4.41, 95% CI=2.03 to 9.59), and those who 
reported any illicit drug use (OR=2.77, 95% CI=1.44 to 5.34). More efforts are needed to enhance 
the utilization of alcohol treatment. Our findings highlight the unique profile of those who utilized 
alcohol treatment. Such information is vital to improve treatment delivery to address unmet need 
in this particular population.
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 1. Introduction
Alcohol use is common among women with HIV infection in the United States. 
Approximately half of HIV-positive women reported any alcohol consumption in the past 
year with 14%–24% drinking at hazardous levels (Cook et al., 2009). Recent studies have 
shown that hazardous drinking, often defined as >7 drinks per week or >3 drinks per 
occasion for women (Willenbring, Massey, & Gardner, 2009), could affect multiple 
outcomes throughout the entire HIV care continuum. Studies have shown that hazardous 
drinking is associated with low engagement and retention in HIV care (Chander, Lau, & 
Moore, 2006 and Cunningham et al., 2006), suboptimal adherence to HIV medication 
(Braithwaite et al., 2005, Chander et al., 2006, Cook et al., 2001 and Hendershot, Stoner, 
Pantalone, & Simoni, 2009), increased HIV viral load (Chander et al., 2006 and Samet et al., 
2005), increased risky sexual behaviors (Hutton et al., 2012), and more rapid HIV disease 
progression (Wu, Metzger, Lynch, & Douglas, 2011). In addition, heavy alcohol 
consumption imposes greater risk for cirrhosis and hepatocellular carcinoma and worsens 
other liver conditions among HIV-positive women with Hepatitis C Virus (HCV) co-
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infection (Cainelli, Concia, & Vento, 2001, Cohen et al., 2002 and Joshi, O’Grady, 
Dieterich, Gazzard, & Agarwal, 2011).
A variety of treatment options are available to address a wide spectrum of unhealthy 
drinking ranging from risky drinking to chronic alcohol dependence (Willenbring et al., 
2009). Prior studies in the United States (US) general population have consistently found 
that participation in alcohol treatment programs, (e.g., detoxification, Alcoholics 
Anonymous or other 12-step programs, halfway houses) improves outcomes in people with 
alcohol use disorders (AUD) (Dawson, Grant, Stinson, & Chou, 2006, Hasin et al., 2013, 
Moos & Moos, 2004, 2006, Timko, Debenedetti, & Billow, 2006 and Ye & Kaskutas, 2009). 
Nevertheless, community studies of treatment patterns among the general population have 
repeatedly demonstrated substantial underutilization of alcohol treatment (Cohen, Feinn, 
Arias, & Kranzler, 2007, Harris & Edlund, 2005, Mojtabai, 2005 and Wu, Ringwalt, & 
Williams, 2003).
Andersen’s Behavioral Model of Health Services Use (Andersen, 2008) has been widely 
used to help better understand access and utilization of health care services 4 (Babitsch, 
Gohl, & von Lengerke, 2012, Dawson, Goldstein, & Grant, 2012, Goldstein, Dawson, & 
Grant, 2010 and Mojtabai, 2005). This model classifies potential individual and contextual 
determinants into 3 domains: predisposing, enabling, and need factors. Predisposing factors 
represent individuals’ predisposition affecting services use, such as demographics, social 
structure, and health beliefs. Enabling factors refer to various characteristics influencing care 
delivery, such as financial or societal sources for care, availability of and access to care 
providers. Need factors include health status assessed by health professionals or perceived 
by patients themselves (e.g., severity of drinking problems, comorbid health conditions, and 
co-existing mental health and substance abuse problems).
Provision of alcohol treatment services may result in substantial benefits in health and 
wellbeing among HIV-positive women who are hazardous drinkers. However, little is known 
about their utilization of alcohol treatment. The objectives of this study were to describe 
utilization and, under the framework of the Andersen’s Behavioral model, to determine 
factors associated with utilization of any alcohol treatment among HIV-positive women with 
hazardous drinking.
 2. Material and Methods
 2.1. Study sample
This study used data from the Women’s Interagency HIV Study (WIHS), the largest, 
observational prospective cohort study of HIV disease in US women (Bacon et al., 2005). 
The WIHS recruited HIV-positive women from 6 study sites across the US: Brooklyn, New 
York; Bronx, New York; Chicago, Illinois; Los Angeles, California; San Francisco, 
California; and Washington, District of Columbia. To better reflect real-world experience of 
HIV disease and management, women were recruited via various venues, including HIV 
primary care clinics, HIV testing sites, hospital-based programs, community outreach sites, 
and research programs (Barkan et al., 1998). The questions assessing alcohol treatment 
utilization were implemented from 1994 to 2002. The present study was a cross-sectional 
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study, in that information from each participant was based on the first visit in which women 
reported hazardous drinking. Written informed consent was obtained for all women 
participating in WIHS and the institutional review board of the University of Florida 
approved this study to analyze existing WIHS data.
 2.2. Measurements
 Hazardous drinking—Alcohol use questions assessed frequency and quantity, and 
weekly alcohol consumption was calculated to define hazardous drinking. The present study 
defined hazardous drinking as >=12 drinks per week (Gordon et al., 2001 and Parsons, 
Golub, Rosof, & Holder, 2007). In the absence of a formal AUD diagnosis in WIHS, using 
this relatively higher criterion than the NIAAA threshold (>7drinks per week or >3 drinks 
per day for women) enhanced the specificity to better identify women who experienced 
alcohol-related negative consequences and hence, were in need of alcohol treatment.
 Alcohol treatment use—Following the alcohol consumption questions, recent use (in 
the past 6 months) of alcohol treatment was assessed by asking: “during the past 6 months
\since your last visit, have you been in an alcohol treatment program? I am interested in any 
alcohol treatment programs you may have been in, including inpatient and/or outpatient 
alcohol detoxification, halfway houses, Alcoholics Anonymous (AA), and/or other alcohol 
treatment programs.” A series of 5 subsequent questions were then asked of those who 
responded affirmatively to that question, inquiring about specific sources of treatment.
Based on the frequency of sources of treatment, we constructed a hierarchy of two mutually 
exclusive types of care (Dawson et al., 2012): utilization of formal sources of care (inpatient 
detox or outpatient alcohol treatment), irrespective of whether any informal sources of care 
were also used, and utilization of informal sources of care (AA, halfway houses, etc) only.
 Predisposing factors—Predisposing characteristics affecting care-seeking behavior 
included age (18–35, 36–42, 43+), race/ethnicity (Hispanic, Black non-Hispanic, and White 
non-Hispanic/other races), educational attainment (<=high school vs. >=college), 
employment status, and marital status (married/cohabiting vs. single/never married).
 Enabling factors—Factors facilitating or acting as barriers to the utilization of alcohol 
treatment included family income (<=12K vs. >12K), health insurance coverage (yes/no), 
and perceived social support (yes/no). Strong support and aid from family members, friends 
and social connections have been associated with greater likelihood of entry into treatment 
(Grant, 1997 and Mowbray, 2014) compared with those who lack such support. A 
dichotomized social support variable was determined by positive responses to all three 
questions in the general social support domain: whether receiving any help (caring for 
children, getting a ride somewhere or borrowing something) from family members and/or 
friends (yes/no); whether receiving comfort and encouragement from family members 
and/or friends (yes/no); whether family members and/or friends listen and/or try to 
understood participants’ concerns (worries/troubles) since the last visit (yes/no) (Barkan et 
al., 1998).
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 Need factors—Need factors included the amount of weekly alcohol intake categorized 
into 3 levels: 12–15, 16–35, and 36+ drinks; presence of depressive symptoms measured as a 
score of the Center for Epidemiological Studies Depression Scale (CES-D) equal or greater 
than 16 (Tandon, Cluxton-Keller, Leis, Le, & Perry, 2012); use of any illicit drugs defined as 
using marijuana, cocaine, “crack” or freebase cocaine, heroin, methadone, and other drugs in 
the past 6 months. Overall health status was measured by a shortened version of the Medical 
Outcome Study (MOS) - HIV health survey scoring from 0 to 100 (Liu et al., 2006). HCV 
status was determined by testing antibody by second-generation or third-generation enzyme 
linked immunoassay (Ortho-Diagnostic Systems, Rochester, New York, USA), testing HCV-
RNA by HCV-branched DNA (Quantiplex 2.0 branched chain DNA-enhanced label 
amplification assay; Bayer-Versant Diagnostics, formerly Chiron Diagnostics, Emeryville, 
California, USA) and by reverse transcriptase polymerase chain reaction (COBAS Amplicor 
HCV Detection Kit, Roche Diagnostic Systems, Pleasanton, California, USA). HIV-RNA 
was measured using the isothermal nucleic acid sequence-based amplification (NASBA/
Nuclisens) method (bio-Merieaux, Durham, North Carolina, USA) with detection limit of 80 
copies/ml.
 2.3. Statistical analysis
Descriptive analyses were performed to describe recent use (in the past 6 months) of any 
alcohol treatment, specific types of treatment, as well as potential predictors. We performed 
logistic regression on each predictor to determine its bivariate association with alcohol 
treatment. Any variable statistically significant at an α of 0.05 from these models as well as 
those that were predefined as important predictors based on prior literature (e.g., age, race, 
social support), were retained in the final multivariable logistic regression models to 
examine independent correlates with receiving any alcohol treatment. A penalized maximum 
likelihood estimation (PMLE), also called Firth bias correction method, was used to reduce 
small sample bias (King & Zeng, 2001).
In multivariable models requiring complete information for all included variables, even 
small amounts of missing data for each of the predictors can result in sizable sample 
reduction. Although the missing data for each variable were no more than 6%, the total 
amount of missing data in the final complete case model accounted for over 17% of the 
whole sample. To remediate this, we used multiple imputation (MI) with a multivariate 
normal approach (Schafer, 1999). We generated 5 copies of complete data sets with missing 
values imputed by random draws from the multiple imputation models. Multivariable 
logistic regression analysis was performed independently on each of the 5 imputed data sets. 
The resulting estimates for each variable were averaged to give a mean estimate and adjusted 
standard error according to Rubin’s rules (Rubin, 1987). No interaction among covariates 
was detected and therefore the final model was presented without the inclusion of any 
interaction terms. All analyses were conducted using SAS statistical package, version 9.4.
 3. Results
This study identified a total of 474 HIV-positive women who reported recent hazardous 
drinking criteria (>=12 weekly drinks). As shown in table 1, 68.8% of the participants were 
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36 years of age or older. The majority of the women were Black non-Hispanic (68.6%), had 
high school or less education (76.8%), and were single or never married (69.8%). Most 
women reported being unemployed (85.6%), having an average household income of no 
more than $12,000 (73.2%), having any kind of health insurance (75.7%), and around 60% 
reported positive responses to all 3 social support questions. A median of 21 drinks per week 
was reported with approximately one fourth (23.4%) of the sample drinking at least 36 
drinks per week over the past 6 months. Depressive symptoms (CES-D>=16) (67.2%) and 
recent illicit drug use (71.9%) were common. More than half of this sample was HIV/HCV-
co-infected.
As shown in table 2, among HIV-positive women with a recent episode of hazardous 
drinking, 19% (n=90) reported recent alcohol treatment utilization. More specifically, 13.7% 
used at least one formal source of care and 5.3% used only informal sources of care. The 
most commonly reported type of treatment was AA (12.9%), followed by inpatient 
detoxification (9.9%) and outpatient alcohol treatment program (7.0%). Half (51%) of 
women who received any alcohol treatment reported using more than one type of alcohol 
treatment. Among women who had used at least one formal source of care, 61.5% also 
attended AA and 20% obtained care from other sources.
Results from the multivariable model suggested those with household income <=$12,000 
had greater odds of utilization of any alcohol treatment than those with higher household 
income (Odds Ratio [OR] = 3.10, 95% CI=1.53 to 6.27). Having social support achieved 
significance with greater odds of obtaining alcohol treatment (OR=1.68, 95% CI=1.00 to 
2.83) after controlling for other covariates. The dose-response association between levels of 
alcohol consumption and odds of utilizing any alcohol treatment persisted after multivariable 
adjustment. Compared with those who reported weekly drinking of 12–15 drinks, women 
who drank 16–35 drinks per week had 3.02 times greater odds of receiving any alcohol 
treatment (OR=3.02, 95% CI=1.47 to 6.23), and the OR escalated to 4.41 when the levels of 
drinking increased to more than 35 drinks per week (OR=4.41, 95% CI=2.03 to 9.59). 
Finally, illicit drug users had greater odds of reporting alcohol treatment utilization 
(OR=2.77, 95% CI=1.44 to 5.34) than non-drug users. No other significant association was 
found.
 4. Discussion
Among HIV-positive women in the WIHS who reported hazardous drinking, one in five 
reported recent utilization of alcohol treatment; and among those women receiving 
treatment, half received multiple types of treatments among which AA was the most 
common; no HIV factors were associated with treatment entry; a mixture of enabling 
(income and social support) and need factors (drinking levels and drug use) were important 
in explaining utilization of alcohol treatment.
The prevalence of alcohol treatment reported by our study was consistent with findings from 
other studies: National Survey on Drug Use and Health (DSDUH) found that among 
individuals with combined AUD or SUD, the prevalence of past-year treatment utilization 
for substance use disorders (SUD) was as high as 22.1% (Mojtabai, 2005). Indeed, studies 
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on low-socioeconomic class women with substance use disorders also revealed that the rates 
of past-year substance abuse treatment could be as high as 44.0% (Hansen et al., 2004 and 
Rosen, Tolman, & Warner, 2004). Mojtabai suggested that the high levels of utilization of 
alcohol or substance abuse treatments may suggest more severe issues of AUD or SUD 
(Mojtabai, 2005).
This study found no statistically significant association of age and race with alcohol 
treatment utilization among HIV-infected women with drinking problems. Previous studies 
have yielded inconsistent results on the association of age with treatment seeking. Some 
studies have found that older individuals were more likely to receive treatment (Cohen et al., 
2007, Grella, Polinsky, Hser, & Perry, 1999, Tighe & Saxe, 2006 and Weisner, Matzger, 
Tam, & Schmidt, 2002) while others have found that younger people were more likely to 
utilize treatment services (Ilgen et al., 2011 and Harris & Bowe, 2008) In terms of race/
ethnicity, our finding is consistent with prior work that found no racial difference in receipt 
of alcohol treatment (Hatzenbuehler, Keyes, Narrow, Grant, & Hasin, 2008).
The finding of the positive association of low income with alcohol treatment utilization was 
generally consistent with prior observations among non-HIV-infected individuals with AUD 
(Cohen et al., 2007, Ilgen et al., 2011 and Mojtabai, 2005). The exact reason for observing 
this association among HIV-infected women is unclear although it can be related to greater 
access to public services and public entitlements among low-income individuals (Weisner, 
1993). Substance abuse treatments have traditionally been closely affiliated with the criminal 
justice and welfare system (Weisner & Schmidt, 1995). Individuals from lower socio-
economic classes are usually over-represented in the criminal justice and welfare system and 
thus, may be more likely to receive treatment for their alcohol and drug abuse problems. For 
example, the most common form of treatment reported in the present study was participation 
in Alcoholic Anonymous, which is available at no cost.
Our finding highlights social support as a potentially important predictor of alcohol 
treatment utilization in HIV-infected women. The effect of social support has been rarely 
investigated in prior alcohol treatment utilization studies as an independent variable (Ilgen et 
al., 2011). Although a full-scale social support measure, like the 27-item social support 
questionnaire (SSQ), was not utilized, we found greater odds of receiving alcohol treatment 
among HIV-infected women with greater social support. Emotional support obtained from 
families and friends may help HIV-infected women overcome significant social stigma 
associated with alcohol abuse and HIV infection and motivate them to seek care for both 
conditions. Also, vital ancillary services provided by women’s social networks, such as 
childcare, transportation, or important family services, may further enhance access to 
alcohol treatment for many HIV-infected women with AUD. Lack of adequate supporting 
system has contributed substantially to low rates of alcohol treatment uptake. Future alcohol 
treatment programs focusing on HIV-infected women may consider the integration of social 
support strategies to facilitate care access and to improve quality of care.
The positive relationship of treatment utilization with drinking levels is self-evident: the 
more alcohol is used, the greater odds that individuals will seek help for their AUD. The 
presence of depressive symptoms appears to play no important role in alcohol treatment 
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utilization among HIV-infected women in this study. Women with depression may lack the 
energy or desire to seek care for drinking problems, which may explain the direction of 
effect found in the analysis. On the other hand, depressed women may seek care for their 
depressive symptoms, in which they may also receive screening or advice about their 
drinking problems (Dawson et al., 2012). Both mechanisms may counterbalance each other, 
resulting in our finding of no effect. Future research should assess whether receiving 
treatment for depression increases the likelihood of seeking alcohol treatment, particularly 
since depression and hazardous drinking frequently co-occur among individuals with HIV 
infection.
In multivariable analyses controlling for predisposing, enabling and levels of alcohol 
consumption, recent illicit drug use predicted the utilization of alcohol treatment. This 
positive association is consistent with prior research that illicit drug use is positively 
associated with care-seeking behaviors (Cohen et al., 2007, Dawson et al., 2012, D. S. 
Hasin, 1994, Ilgen et al., 2011 and Mojtabai, Olfson, & Mechanic, 2002). Cohen and 
colleagues (2007) suggested that comorbid substance use disorders had strong influence on 
alcohol treatment utilization. In the current study, co-occurring drug use was reported by 
more than two thirds of the sample and may result in greater distress experienced by HIV-
positive women, increasing their motivation to seek care for drinking problems. Increased 
outreach to those with both alcohol and drug use problems could help target the population 
with the most need for treatment.
This study has several limitations. First, our findings of predictors of utilization of alcohol 
treatment should not be interpreted as a causal link because of the cross-sectional study 
design. Second, the data on alcohol treatment utilization were based on self-report questions 
with unknown validity and reliability. Additionally, our measure of care did not allow us to 
distinguish participants with voluntary utilization from those with coerced utilization or to 
distinguish those who were unable to get care from those who never sought care. Third, the 
small number of respondents who reported recent treatment utilization precluded our 
analysis to identify meaningful factors associated with different types of alcohol treatment. 
Fourth, WIHS is a convenience sample but is representative of women with HIV in the US. 
WIHS women had semiannual visits with WIHS staff, which may influence hazardous 
drinkers’ care seeking behaviors. Therefore, our results may not be generalizable to all HIV-
infected women with drinking problems. Fifth, although the formal diagnosis of AUD is 
lacking for our sample, quantity and frequency questions of alcohol consumption have been 
widely used to identify people with drinking problems (Canagasaby & Vinson, 2005, Chung 
et al., 2012, Dawson, Grant, Stinson, & Zhou, 2005, Rubinsky, Dawson, Williams, Kivlahan, 
& Bradley, 2013 and Willenbring et al., 2009). In addition, we choose a higher cut-off point 
to define hazardous drinking, resulting in higher specificity in identifying subjects in need of 
treatment. Sixth, mental health disorders were not assessed in this study with the exception 
of depressive symptoms. Comorbid personality disorders and anxiety disorders may also 
play important roles in determining alcohol treatment utilization. Finally, the timeframe of 
the data collection is limited in this study. However, there have been few advances in the 
types of alcohol treatments, alcohol treatment utilizations since that time (Harris et al., 
2012). Therefore, most of findings of the current study should be relevant today.
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Despite the above limitations, this is the first study of which we are aware to examine 
predictors of utilization of alcohol treatment among HIV-positive women. Our findings 
provide a unique profile of HIV-infected women with hazardous drinking who received 
alcohol treatments. This information is important to improve the treatment service delivery 
to this population. Many HIV-infected women who do not receive care for their AUD can 
potentially benefit from engaging in alcohol treatment by improving outcomes across the 
entire HIV care cascade, including engagement in care, receipt of ART, adherence to 
therapy, and achieving viral suppression (Kyser et al., 2011 and Michel et al., 2010). 
Improved screening for at-risk drinking, referral to appropriate treatment, and integrating 
treatment procedures tailored to the unique contexts for HIV-infected women (e.g. combined 
treatment services to address drug and alcohol dependence, the availability of auxiliary 
services) could potentially help lessen the gap between need for and the utilization of 
alcohol treatment.
 Acknowledgments
This work was supported by a grant from the National Institutes of Health (U01-AA020797). Data in this 
manuscript were collected by the Women’s Interagency HIV Study (WIHS). The contents of this publication are 
solely the responsibility of the authors and do not represent the official views of the National Institutes of Health 
(NIH). WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag, Mirjam-Colette Kempf, and Deborah 
Konkle-Parker), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; 
Bronx WIHS (Kathryn Anastos), U01-AI-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), 
U01-AI-031834; Chicago WIHS (Mardge Cohen), U01-AI-034993; Metropolitan Washington WIHS (Mary 
Young), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora 
Adimora), U01-AI-103390; Connie Wofsy Women’s HIV Study, Northern California (Ruth Greenblatt, Bradley 
Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and 
Elizabeth Golub), U01-AI-042590; Southern California WIHS (Alexandra Levine and Marek Nowicki), U01-
HD-032632 (WIHS I – WIHS IV). The WIHS is funded primarily by the National Institute of Allergy and 
Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of 
Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on 
Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for 
specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the 
National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other 
Communication Disorders (NIDCD), and the NIH Office of Research on Women’s Health. WIHS data collection is 
also supported by UL1-TR000004 (UCSF CTSA) and UL1-TR000454 (Atlanta CTSA).
Reference
Andersen RM. National Health Surveys and the Behavioral Model of Health Services Use. Medical 
Care July 2008. 2008; 46(7):647–653.
Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s Behavioral Model of Health Services 
Use: a systematic review of studies from 1998–2011. Psycho-Social Medicine. 2012 Doc;9
Bacon MC, Wyl V, von Alden C, Sharp G, Robison E, Hessol N, Young MA. The Women’s 
Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench. Clinical 
and Diagnostic Laboratory Immunology. 2005; 12(9)
Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Feldman J. The Women’s 
Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology (Cambridge, Mass.). 
1998; 9(2):117–125.
Braithwaite S, McGinnis KA, Conigliaro J, Maisto SA, Crystal S, Day N, Justice AC. A temporal and 
dose-response association between alcohol consumption and medication adherence among veterans 
in care. Alcoholism, Clinical and Experimental Research. 2005; 29(7):1190–1197.
Cainelli F, Concia E, Vento S. Mortality due to hepatitis C virus-related cirrhosis in patients infected 
with HIV type 1: a role for alcohol. Clinical Infectious Diseases: An Official Publication of the 
Infectious Diseases Society of America. 2001; 33(10):1795–1797. [PubMed: 11641833] 
Hu et al. Page 9
J Subst Abuse Treat. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Canagasaby A, Vinson DC. Screening for hazardous or harmful drinking using one or two quantity-
frequency questions. Alcohol and Alcoholism (Oxford, Oxfordshire). 2005; 40(3):208–213.
Chander G, Lau B, Moore RD. Hazardous Alcohol Use: A Risk Factor for Non-Adherence and Lack 
of Suppression in HIV Infection. Journal of Acquired Immune Deficiency Syndromes (1999). 2006; 
43(4):411–417. [PubMed: 17099312] 
Chung T, Smith GT, Donovan JE, Windle M, Faden VB, Chen CM, Martin CS. Drinking Frequency as 
a Brief Screen for Adolescent Alcohol Problems. Pediatrics. 2012; 129(2):205–212. [PubMed: 
22218839] 
Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National 
Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence. 2007; 
86(2–3):214–221. [PubMed: 16919401] 
Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, Hessol NA. Causes of death 
among women with human immunodeficiency virus infection in the era of combination 
antiretroviral therapy. The American Journal of Medicine. 2002; 113(2):91–98. [PubMed: 
12133746] 
Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and 
medication adherence among persons with HIV infection. Journal of General Internal Medicine. 
2001; 16(2):83–88. [PubMed: 11251758] 
Cook RL, Zhu F, Belnap BH, Weber K, Cook JA, Vlahov D, Cohen MH. Longitudinal trends in 
hazardous alcohol consumption among women with human immunodeficiency virus infection, 
1995–2006. American Journal of Epidemiology. 2009; 169(8):1025–1032. [PubMed: 19270052] 
Cunningham WE, Sohler NL, Tobias C, Drainoni M, Bradford J, Davis C, Wong MD. Health services 
utilization for people with HIV infection: comparison of a population targeted for outreach with 
the U.S. population in care. Medical Care. 2006; 44(11):1038–1047. [PubMed: 17063136] 
Dawson DA, Goldstein RB, Grant BF. Factors associated with first utilization of different types of care 
for alcohol problems. Journal of Studies on Alcohol and Drugs. 2012; 73(4):647–656. [PubMed: 
22630803] 
Dawson DA, Grant BF, Stinson FS, Chou PS. Estimating the effect of help-seeking on achieving 
recovery from alcohol dependence. Addiction (Abingdon, England). 2006; 101(6):824–834.
Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders 
Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US 
general population. Alcoholism, Clinical and Experimental Research. 2005; 29(5):844–854.
Goldstein RB, Dawson DA, Grant BF. Antisocial Behavioral Syndromes in Adulthood and Alcohol 
Use Disorder Treatment Over Three-Year Follow-Up: Results From Wave 2 of the National 
Epidemiologic Survey on Alcohol and Related Conditions. Journal of the American Psychiatric 
Nurses Association. 2010; 16(4):212–226. [PubMed: 20838468] 
Gordon AJ, Maisto SA, McNeil M, Kraemer KL, Conigliaro RL, Kelley ME, Conigliaro J. Three 
questions can detect hazardous drinkers. The Journal of Family Practice. 2001; 50(4):313–320. 
[PubMed: 11300982] 
Grant BF. Barriers to alcoholism treatment: reasons for not seeking treatment in a general population 
sample. Journal of Studies on Alcohol. 1997; 58(4):365–371. [PubMed: 9203117] 
Grella CE, Polinsky ML, Hser YI, Perry SM. Characteristics of women-only and mixed-gender drug 
abuse treatment programs. Journal of Substance Abuse Treatment. 1999; 17(1–2):37–44. 
[PubMed: 10435251] 
Hansen H, Alegria M, Caban CAM, Pena MM, Lai S, Shrout P. Drug Treatment, Health, and Social 
Service Utilization by Substance Abusing Women From a Community-Based Sample. Medical 
Care November 2004. 2004; 42(11):1117–1124.
Harris AHS, Oliva E, Bowe T, Humphreys KN, Kivlahan DR, Trafton JA. Pharmacotherapy of alcohol 
use disorders by the Veterans Health Administration: patterns of receipt and persistence. 
Psychiatric Services (Washington, D.C.). 2012; 63(7):679–685.
Harris KM, Edlund MJ. Use of Mental Health Care and Substance Abuse Treatment Among Adults 
With Co-occurring Disorders. Psychiatric Services. 2005; 56(8):954–959. [PubMed: 16088012] 
Hasin DS. Treatment/self-help for alcohol-related problems: relationship to social pressure and alcohol 
dependence. Journal of Studies on Alcohol. 1994; 55(6):660–666. [PubMed: 7861793] 
Hu et al. Page 10
J Subst Abuse Treat. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hasin DS, Aharonovich E, O’Leary A, Greenstein E, Pavlicova M, Arunajadai S, Johnston B. 
Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and 
without technological enhancement. Addiction (Abingdon, England). 2013; 108(7):1230–1240.
Hatzenbuehler ML, Keyes KM, Narrow WE, Grant BF, Hasin DS. Racial/ethnic disparities in service 
utilization for individuals with co-occurring mental health and substance use disorders in the 
general population. The Journal of Clinical Psychiatry. 2008; 69(7):1112–1121. [PubMed: 
18517286] 
Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: 
Review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 2009; 
52(2):180. [PubMed: 19668086] 
Hutton HE, McCaul ME, Chander G, Jenckes MW, Nollen C, Sharp VL, Erbelding EJ. Alcohol Use, 
Anal Sex, and Other Risky Sexual Behaviors Among HIV-Infected Women and Men. AIDS and 
Behavior. 2012:1–11. [PubMed: 21476006] 
Ilgen MA, Price AM, Burnett-Zeigler I, Perron B, Islam K, Bohnert ASB, Zivin K. Longitudinal 
predictors of addictions treatment utilization in treatment-naïve adults with alcohol use disorders. 
Drug and Alcohol Dependence. 2011; 113(2–3):215–221. [PubMed: 20828944] 
Joshi D, O’Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients 
with HIV infection. The Lancet. 2011; 377(9772):1198–1209.
Kessler RC, Aguilar-Gaxiola S, Berglund PA, et al. PAtterns and predictors of treatment seeking after 
onset of a substance use disorder. Archives of General Psychiatry. 2001; 58(11):1065–1071. 
[PubMed: 11695954] 
King G, Zeng L. Logistic Regression in Rare Events Data. Political Analysis. 2001; 9(2):137–163.
Kyser M, Buchacz K, Bush TJ, Conley LJ, Hammer J, Henry K, Brooks JT. Factors associated with 
non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011; 23(5):601–611. 
[PubMed: 21293992] 
Liu C, Weber K, Robison E, Hu Z, Jacobson LP, Gange SJ. Assessing the effect of HAART on change 
in quality of life among HIV-infected women. AIDS Research and Therapy. 2006; 3(1):6. 
[PubMed: 16549012] 
Michel L, Carrieri MP, Fugon L, Roux P, Aubin H-J, Lert F. group the V study. Harmful alcohol 
consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals 
(ANRS-EN12-VESPA Study): relevance for clinical management and intervention. AIDS Care. 
2010; 22(9):1136–1145. [PubMed: 20824566] 
Mojtabai R. Use of specialty substance abuse and mental health services in adults with substance use 
disorders in the community. Drug and Alcohol Dependence. 2005; 78(3):345–354. [PubMed: 
15893166] 
Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or 
substance use disorders. Archives of General Psychiatry. 2002; 59(1):77–84. [PubMed: 11779286] 
Moos RH, Moos BS. Long-Term Influence of Duration and Frequency of Participation in Alcoholics 
Anonymous on Individuals With Alcohol Use Disorders. Journal of Consulting and Clinical 
Psychology. 2004; 72(1):81–90. [PubMed: 14756617] 
Moos RH, Moos BS. Rates and predictors of relapse after natural and treated remission from alcohol 
use disorders. Addiction. 2006; 101(2):212–222. [PubMed: 16445550] 
Mowbray O. The moderating role of social networks in the relationship between alcohol consumption 
and treatment utilization for alcohol-related problems. Journal of Substance Abuse Treatment. 
2014; 46(5):597–601. [PubMed: 24462223] 
Parsons JT, Golub SA, Rosof E, Holder C. Motivational Interviewing and Cognitive-Behavioral 
Intervention to Improve HIV Medication Adherence Among Hazardous Drinkers: A Randomized 
Controlled Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2007; 46(4):443–
450. [PubMed: 18077833] 
Rosen D, Tolman RM, Warner LA. Low-income women’s use of substance abuse and mental health 
services. Journal of Health Care for the Poor and Underserved. 2004; 15(2):206–219. [PubMed: 
15253374] 
Hu et al. Page 11
J Subst Abuse Treat. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Rubin, DB. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons, Inc; 1987. 
Frontmatter; p. i-xxix.Retrieved from http://onlinelibrary.wiley.com/doi/
10.1002/9780470316696.fmatter/summary
Rubinsky AD, Dawson DA, Williams EC, Kivlahan DR, Bradley KA. AUDIT-C scores as a scaled 
marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol 
dependence in a U.S. general population sample of drinkers. Alcoholism, Clinical and 
Experimental Research. 2013; 37(8):1380–1390.
Samet JH, Horton NJ, Meli S, Dukes K, Tripps T, Sullivan L, Freedberg KA. A randomized controlled 
trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. 
Antiviral Therapy. 2005; 10(1):83–93. [PubMed: 15751766] 
Schafer JL. Multiple imputation: a primer. Statistical Methods in Medical Research. 1999; 8(1):3–15. 
[PubMed: 10347857] 
S H, Bowe T. Predictors of initiation and engagement in VA substance use disorder (SUD) treatment. 
Psychological Services. 2008; 5(3):228–238.
Tandon SD, Cluxton-Keller F, Leis J, Le H-N, Perry DF. A comparison of three screening tools to 
identify perinatal depression among low-income African American women. Journal of Affective 
Disorders. 2012; 136(1–2):155–162. [PubMed: 21864914] 
Tighe E, Saxe L. Community-Based Substance Abuse Reduction and the Gap between Treatment Need 
and Treatment Utilization: Analysis of Data from the “Fighting Back” General Population Survey. 
Journal of Drug Issues. 2006; 36(2):295–312.
Timko C, Debenedetti A, Billow R. Intensive referral to 12-Step self-help groups and 6-month 
substance use disorder outcomes. Addiction (Abingdon, England). 2006; 101(5):678–688.
Weisner C. Toward an Alcohol Treatment Entry Model: A Comparison of Problem Drinkers in the 
General Population and in Treatment. Alcoholism: Clinical and Experimental Research. 1993; 
17(4):746–752.
Weisner C, Matzger H, Tam T, Schmidt L. Who Goes to Alcohol and Drug Treatment? Understanding 
Utilization within the Context of Insurance. Journal of Studies on Alcohol and Drugs. 2002; 63(6):
673.
Weisner C, Schmidt LA. Expanding the frame of health services research in the drug abuse field. 
Health Services Research. 1995; 30(5):707–726. [PubMed: 8537228] 
Willenbring ML, Massey SH, Gardner MB. Helping patients who drink too much: an evidence-based 
guide for primary care clinicians. American Family Physician. 2009; 80(1):44–50. [PubMed: 
19621845] 
Wu ES, Metzger DS, Lynch KG, Douglas SD. Association between Alcohol Use and HIV Viral Load. 
Journal of Acquired Immune Deficiency Syndromes (1999). 2011; 56(5):129–130.
Wu L-T, Ringwalt CL, Williams CE. Use of Substance Abuse Treatment Services by Persons With 
Mental Health and Substance Use Problems. Psychiatric Services. 2003; 54(3):363–369. [PubMed: 
12610245] 
Ye Y, Kaskutas LA. Using propensity scores to adjust for selection bias when assessing the 
effectiveness of Alcoholics Anonymous in observational studies. Drug and Alcohol Dependence. 
2009; 104(1–2):56–64. [PubMed: 19457623] 
Hu et al. Page 12
J Subst Abuse Treat. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Highlight
• Less than one in five HIV+ women with hazardous drinking reported 
recent use of any alcohol treatment.
• Half of HIV+ women receiving any alcohol treatment reported 
receiving multiple treatment services among which Alcoholic 
Anonymous (AA) was the most common.
• A mixture of factors (income levels, social support, drinking levels, and 
drug use) was important in explaining utilization of alcohol treatment 
among HIV+ women with hazardous drinking.
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Table 1
Characteristics of 474 HIV-positive WIHS women with recent hazardous drinking (in the past 6 months)
Characteristics
All
(n=474)
%
Predisposing
Age (years)
    18–35 31.2
    36–42 38.2
    43+ 30.6
Race/ethnicity
    Black non-Hispanic 68.6
    Hispanic any race 16.7
    White non-Hispanic/other 14.8
Education
    <=High school 76.8
    >=College 23.2
Marital status
    Married/cohabitating 30.2
    Single/never married 69.8
Enabling
Income
    <=12K 73.2
    >12K 26.8
Employed 14.4
Any health insurance 75.7
Social support 60.4
Need
Number of drinks per week
    36+ 23.4
    16–35 50.8
    12–15 25.7
Depression (CES-D>=16) 67.2
Any drug use 71.9
Quality of life (mean, SD) 58.0 (20.2)
HCV 59.8
Undetected HIV viral load 9.1
CD4>200 cells /mm3 77.7
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Table 2
Recent alcohol treatment services utilization among HIV-positive women with hazardous drinking
Type of alcohol treatment services
All
(n=474)
%
Formal
sources of
care
(n=65)
%
Informal
sources of
care only
(n=25)
%
Any alcohol treatment service a 19.0
Formal sources of care (inpatient detox or
outpatient alcohol treatment)b
13.7 100.0 0.0
Informal sources of care only (AA,
halfway houses, etc)
5.3 0.0 100.0
Inpatient alcohol detoxification 9.9 72.3 c 0.0
Outpatient alcohol treatment program 7.0 50.8 0.0
Alcoholic Anonymous (AA) 12.9 61.5 84.0
Other (halfway houses, etc.) 4.2 20.0 28.0
aAny alcohol treatment used in the past 6 months includes uptake of any formal (inpatient detoxification, outpatient alcohol treatment, etc.) or 
informal sources of care for alcohol problems (Alcoholic Anonymous, halfway house, etc.).
b
Irrespective of whether also used any informal sources of care
c
Do not add up to 100% because some women used multiple sources of treatment
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